MedPath

Result of life style modification to fatty liver in person outrange BMI and/or steatosis in 6 to 12 months

Phase 2
Conditions
Patients who are overweight or have steatosis
fatty liver
Body mass index
steatosis
life style
Registration Number
TCTR20221228002
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
nknown
Sex
All
Target Recruitment
40
Inclusion Criteria

1. healthy person with overweight/obese(high BMI), and/or 2. non viral hepatitis(mild degree), and/or 3. fatty liver (from fibroscan)

Exclusion Criteria

None

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
liver fat at 6 months after end of the intervention fibroscan
Secondary Outcome Measures
NameTimeMethod
/A N/A N/A
© Copyright 2025. All Rights Reserved by MedPath